№ lp_2_3_12301
File format: docx
Character count: 954008
File size: 4054 KB
Annual report filed with a federal securities regulator presenting corporate, financial, governance, and risk disclosures of a publicly traded biotechnology company for the fiscal year ended December 31, 2024.
Filing Type:
Form 10-K Annual Report
Fiscal Year Ended:
December 31, 2024
Registrant:
Monte Rosa Therapeutics, Inc.
State of Incorporation:
Delaware
I.R.S. Employer Identification No.:
84-3766197
Principal Executive Offices:
321 Harrison Avenue, Suite 900, Boston, Massachusetts 02118
Telephone:
(617) 949-2643
Commission File Number:
001-40522
Regulatory Authority:
United States Securities and Exchange Commission
Securities Exchange:
The Nasdaq Global Select Market
Trading Symbol:
GLUE
Security Registered:
Common stock, par value $0.0001 per share
Market Value of Non-Affiliate Common Equity (as of June 30, 2024):
$199 million
Shares Outstanding (as of March 17, 2025):
61,509,821
Reporting Status:
Non-accelerated filer; Smaller reporting company; Emerging growth company
Incorporated Documents:
Portions of definitive proxy statement for annual meeting of shareholders
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2024
Region / city:
Delaware, USA
Theme:
Business operations, financial report
Document type:
Annual report
Institution:
U.S. Securities and Exchange Commission
Author:
BAB, Inc.
Target audience:
Investors, financial analysts, regulators
Period of validity:
Fiscal year ending November 30, 2024
Approval date:
Not specified
Date of amendments:
Not specified
Year:
2024
Region / City:
Redmond, Washington
Topic:
Annual financial report
Document Type:
Financial report
Organization:
Microsoft Corporation
Author:
Microsoft Corporation
Target Audience:
Investors, analysts, shareholders
Period of Validity:
Fiscal year ended June 30, 2024
Approval Date:
Not specified
Amendment Date:
Not specified
Year:
2011
Region / City:
United States
Topic:
Securities and Exchange
Document Type:
Annual Report
Organ / Institution:
Comcast Corporation
Author:
Comcast Corporation
Target Audience:
Shareholders, Investors
Period of Action:
Fiscal Year 2011
Approval Date:
Not specified
Modification Date:
Not specified
Year:
2015
Region / City:
Bethesda, Maryland
Topic:
Corporate Annual Report
Document Type:
Report
Organization:
Lockheed Martin Corporation
Author:
Lockheed Martin Corporation
Target Audience:
Investors, regulators, stakeholders
Effective Period:
Fiscal year 2015
Date of Approval:
N/A
Date of Modifications:
N/A
Year:
2025
Company:
ITT Inc.
State of Incorporation:
Indiana
IRS Employer Identification Number:
81-1197930
Address:
100 Washington Boulevard, 6th Floor, Stamford, CT 06902
Telephone:
(914) 641-2000
Type of Document:
Annual report (Form 10-K)
Exchange:
New York Stock Exchange
Trading Symbol:
ITT
Market Value of Common Stock:
$12.2 billion as of June 30, 2025
Shares Outstanding:
86.0 million as of February 6, 2026
Filing Status:
Large accelerated filer
Internal Control Assessment:
Filed under Section 404(b) of Sarbanes-Oxley Act
Reference Documents:
Portions of Definitive Proxy Statement for 2026 Annual Meeting of Shareholders incorporated by reference
Year:
2025
Fiscal year end:
March 31, 2025
Date:
July 7, 2025
Country:
United States
City:
Washington, D.C.
Company:
Orion Energy Systems, Inc.
Industry:
Energy systems and LED lighting solutions
Document type:
Annual report (Form 10-K)
Regulatory authority:
United States Securities and Exchange Commission
CEO:
Sally Washlow
Headquarters address:
2210 Woodland Drive, Manitowoc, WI 54220, United States
Stock exchange:
Nasdaq Stock Market LLC (NASDAQ Capital Market)
Ticker symbol:
OESX
Incorporation state:
Wisconsin
IRS Employer Identification Number:
39-1847269
Shares outstanding (May 30, 2025):
33,305,699
Market value of shares held by non-affiliates (September 30, 2024):
$28,196,921
Revenue FY2025:
$79.7 million
Net loss FY2025:
$11.8 million
Gross margin FY2025:
25.4%
Operating expenses FY2025:
$30.8 million
Annual shareholders’ meeting:
August 7, 2025
Note:
Year
Subject:
Overseas Portfolio Investment Reporting
Document Type:
Form
Year:
2020
Type of document:
Advisory letter
Subject:
Tax treatment of superannuation contributions
Audience:
Individual clients
Jurisdiction:
Australia
Issuing organization:
[Company Name]
Author:
[Insert Client Position / Author not explicitly stated]
Period covered:
Financial year ended 30 June 2020
Contribution types:
Concessional and non-concessional
Relevant legislation:
Division 293 tax, concessional contributions caps
Year:
2017
Region / city:
Chengdu, People’s Republic of China
Topic:
Intangible Cultural Heritage, UNESCO, Results Framework
Document Type:
Meeting Summary
Organ / Institution:
UNESCO Intergovernmental Committee for the Safeguarding of the Intangible Cultural Heritage
Author:
UNESCO Secretariat
Target Audience:
States Parties to the 2003 Convention, Cultural Heritage Experts
Period of validity:
N/A
Date of approval:
N/A
Date of changes:
N/A
Year:
2024
Region / City:
West Sussex
Theme:
Financial Statements, Charity
Document Type:
Financial Report
Organization:
Association of Dental Implantology Ltd
Author:
Mark Cummins FCCA FCIE
Target Audience:
Charity Trustees, Financial Stakeholders
Period of Activity:
1 August 2023 – 31 July 2024
Approval Date:
18 November 2024
Date of Changes:
None
Year:
2006
Region / City:
Australia
Subject:
Education
Document Type:
Policy
Author:
Department of Education
Target Audience:
School administration
Period of Validity:
Not specified
Approval Date:
Not specified
Amendment Date:
Not specified
Year:
2026
Note:
Region / City
Theme:
Financial viability, Risk assessment
Document Type:
Risk Assessment
Period of validity:
2025-2026
Contextual Description:
This document provides a financial risk assessment methodology for schools participating in the Private School Choice Programs, focusing on financial viability indicators for the 2025-26 school year.
Year:
2025
Region / City:
Virginia
Subject:
Pre-Medicare Retiree Healthcare Program
Document Type:
Instructions
Agency:
Department of Human Resource Management
Audience:
Agencies
Period of validity:
Fiscal Year 2025
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2025
Region / City:
Missouri
Topic:
Education Statistics
Document Type:
Report
Organization / Institution:
Missouri Department of Elementary and Secondary Education
Author:
Unknown
Target Audience:
School Districts, Charter Schools, Independent Auditors
Period of Validity:
Until June 2025
Approval Date:
Unknown
Date of Amendments:
Unknown
Year:
2025
Region / City:
Missouri
Topic:
School Finance
Document Type:
User Guide
Agency / Institution:
Missouri Department of Elementary and Secondary Education
Author:
Missouri Department of Elementary and Secondary Education
Target Audience:
School Districts, Charter Schools, Independent Auditors
Effective Period:
Year Ended June 30, 2025
Approval Date:
Not specified
Amendment Date:
Not specified
Year:
2024
Region / city:
Delaware, USA
Theme:
Business operations, financial report
Document type:
Annual report
Institution:
U.S. Securities and Exchange Commission
Author:
BAB, Inc.
Target audience:
Investors, financial analysts, regulators
Period of validity:
Fiscal year ending November 30, 2024
Approval date:
Not specified
Date of amendments:
Not specified
Year:
[DD MM YYYY]
Region / City:
Singapore
Subject:
Companies Act 1967, financial statements filing
Document Type:
Declaration
Organization:
ACRA (Accounting and Corporate Regulatory Authority)
Author:
Director and Authorized Representative of Foreign Company
Target Audience:
Registrar of Companies, Foreign Company, Singapore Branch
Period of Effect:
Financial Year Ended [DD MM YYYY]
Approval Date:
[DD MM YYYY]
Date of Amendments:
Not specified
Year:
20xx
Region / City:
Louisiana
Subject:
Agreed-Upon Procedures, Compliance and Control Review
Document Type:
Engagement Letter
Organization / Institution:
CPA Firm
Author:
CPA Firm
Target Audience:
Entity Head, Louisiana Legislative Auditor (LLA)
Period of Validity:
Fiscal period ended June 30, 20xx
Approval Date:
[Date]
Date of Modifications:
[Date]
Year:
20XX
Region / City:
Louisiana
Topic:
Control and compliance procedures
Organization / Institution:
Louisiana Legislative Auditor (LLA)
Author:
XYZ Entity
Target Audience:
Governing Board of XYZ Entity, Louisiana Legislative Auditor
Period of validity:
July 1, 20XX through June 30, 20XX
Approval date:
Not provided
Date of amendments:
Not provided
Year:
2024
Region / City:
[Country]
Theme:
Financial Reporting, Banking
Document Type:
Financial Statement, Report
Organization:
ABC Bank Group
Author:
Management Board
Target Audience:
Shareholders, Investors, Regulatory Bodies
Period of Validity:
Year ending 31 December 2024
Date of Approval:
[Date to be inserted in the document]
Date of Changes:
N/A